EP3696534A1 - Procédé pour déterminer les propriétés physicochimiques de systèmes nanométriques (nss) - Google Patents
Procédé pour déterminer les propriétés physicochimiques de systèmes nanométriques (nss) Download PDFInfo
- Publication number
- EP3696534A1 EP3696534A1 EP19157202.3A EP19157202A EP3696534A1 EP 3696534 A1 EP3696534 A1 EP 3696534A1 EP 19157202 A EP19157202 A EP 19157202A EP 3696534 A1 EP3696534 A1 EP 3696534A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- nss
- sample
- sedimentation
- ndds
- auc
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 55
- 238000013103 analytical ultracentrifugation Methods 0.000 claims abstract description 58
- 238000004062 sedimentation Methods 0.000 claims description 139
- 239000003814 drug Substances 0.000 claims description 69
- 229940079593 drug Drugs 0.000 claims description 68
- 239000002904 solvent Substances 0.000 claims description 43
- 238000001514 detection method Methods 0.000 claims description 38
- 230000015556 catabolic process Effects 0.000 claims description 34
- 238000006731 degradation reaction Methods 0.000 claims description 34
- 238000005259 measurement Methods 0.000 claims description 33
- 238000004458 analytical method Methods 0.000 claims description 32
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 230000008685 targeting Effects 0.000 claims description 19
- 230000003287 optical effect Effects 0.000 claims description 18
- 230000001419 dependent effect Effects 0.000 claims description 16
- 239000012530 fluid Substances 0.000 claims description 15
- 238000012377 drug delivery Methods 0.000 claims description 12
- 239000004094 surface-active agent Substances 0.000 claims description 12
- 239000000126 substance Substances 0.000 claims description 10
- 238000010521 absorption reaction Methods 0.000 claims description 6
- 229920002988 biodegradable polymer Polymers 0.000 claims description 5
- 239000004621 biodegradable polymer Substances 0.000 claims description 5
- 239000012266 salt solution Substances 0.000 claims description 3
- 239000003381 stabilizer Substances 0.000 claims description 3
- 238000004364 calculation method Methods 0.000 claims description 2
- 238000007385 chemical modification Methods 0.000 claims description 2
- 238000004141 dimensional analysis Methods 0.000 claims 1
- 239000000523 sample Substances 0.000 description 70
- 238000002474 experimental method Methods 0.000 description 52
- 239000002245 particle Substances 0.000 description 52
- 239000000243 solution Substances 0.000 description 39
- 238000003860 storage Methods 0.000 description 33
- 238000002835 absorbance Methods 0.000 description 30
- 238000009826 distribution Methods 0.000 description 27
- 239000006228 supernatant Substances 0.000 description 26
- 210000002966 serum Anatomy 0.000 description 20
- 229920002451 polyvinyl alcohol Polymers 0.000 description 19
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 16
- 239000001963 growth medium Substances 0.000 description 14
- 239000002105 nanoparticle Substances 0.000 description 14
- 238000009472 formulation Methods 0.000 description 12
- 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 10
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 9
- 239000007787 solid Substances 0.000 description 9
- 238000010790 dilution Methods 0.000 description 8
- 239000012895 dilution Substances 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 101150094382 NSS gene Proteins 0.000 description 7
- 239000011159 matrix material Substances 0.000 description 7
- 229920000642 polymer Polymers 0.000 description 7
- 239000002041 carbon nanotube Substances 0.000 description 6
- 238000012512 characterization method Methods 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 5
- 230000003993 interaction Effects 0.000 description 5
- 239000002502 liposome Substances 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 239000000654 additive Substances 0.000 description 4
- 239000013060 biological fluid Substances 0.000 description 4
- 229910021393 carbon nanotube Inorganic materials 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- -1 e.g. Substances 0.000 description 4
- 238000011065 in-situ storage Methods 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000004044 response Effects 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 239000006143 cell culture medium Substances 0.000 description 3
- 230000000875 corresponding effect Effects 0.000 description 3
- 238000007405 data analysis Methods 0.000 description 3
- 239000000412 dendrimer Substances 0.000 description 3
- 229920000736 dendritic polymer Polymers 0.000 description 3
- 238000013461 design Methods 0.000 description 3
- 239000010931 gold Substances 0.000 description 3
- 229910052737 gold Inorganic materials 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000002609 medium Substances 0.000 description 3
- 239000013528 metallic particle Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 239000002047 solid lipid nanoparticle Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 102000004506 Blood Proteins Human genes 0.000 description 2
- 108010017384 Blood Proteins Proteins 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Natural products OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 108010020147 Protein Corona Proteins 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 238000012544 monitoring process Methods 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 230000001376 precipitating effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000003252 repetitive effect Effects 0.000 description 2
- 239000013049 sediment Substances 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- 238000012421 spiking Methods 0.000 description 2
- 230000000087 stabilizing effect Effects 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 239000000232 Lipid Bilayer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 239000012472 biological sample Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007596 consolidation process Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 238000011157 data evaluation Methods 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000010249 in-situ analysis Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 239000002608 ionic liquid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000007769 metal material Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 150000002739 metals Chemical class 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 238000000329 molecular dynamics simulation Methods 0.000 description 1
- 239000002091 nanocage Substances 0.000 description 1
- 239000002539 nanocarrier Substances 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 235000004252 protein component Nutrition 0.000 description 1
- 230000004850 protein–protein interaction Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000012797 qualification Methods 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 238000009877 rendering Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- 238000002211 ultraviolet spectrum Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 238000003260 vortexing Methods 0.000 description 1
Images
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/04—Investigating sedimentation of particle suspensions
- G01N15/042—Investigating sedimentation of particle suspensions by centrifuging and investigating centrifugates
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N11/00—Investigating flow properties of materials, e.g. viscosity, plasticity; Analysing materials by determining flow properties
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N2015/0038—Investigating nanoparticles
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/04—Investigating sedimentation of particle suspensions
- G01N15/042—Investigating sedimentation of particle suspensions by centrifuging and investigating centrifugates
- G01N2015/045—Investigating sedimentation of particle suspensions by centrifuging and investigating centrifugates by optical analysis
Definitions
- the invention relates to a method for determining the physicochemical properties of a nanoscale system (NSS) using analytical ultracentrifugation according to the subject matter of claim 1.
- NSS nanoscale system
- the invention relates to a system for performing the method according to the subject matter of claim 19.
- nanotechnology is thought to promote widespread clinical utilization of drugs, whose access to their site of action has so far been hampered by multiple enroute barriers.
- biocompatible nanocarriers such as liposomes, polymers, inorganic nanoparticles, carbon nanotubes etc.
- improved delivery of e.g. drugs with limited water solubility may be achieved thus increasing the bioavailability of these drugs in biological systems.
- targeting features into nanoparticles, drug delivery to specific organs and to tissues located therein is possible.
- NSS nanoscale systems
- the invention in a first aspect, relates to a method for determining the physicochemical properties of a nanoscale system (NSS) using analytical ultracentrifugation (AUC).
- AUC analytical ultracentrifugation
- the method comprises as a first step the generation of a multi-dimensional sedimentation analysis map associated with the NSS of interest, followed by the second step of selecting AUC parameters depending on the sample.
- the sedimentation coefficient value per parameter is determined in the sample, e.g.
- each parameter (viscosity, density, etc.) is determined in the sample
- the sample sedimentation coefficient values are inserted onto the multi-dimensional sedimentation analysis map to obtain an NSS sample map value.
- the sample values are mapped onto the multi-dimensional sedimentation analysis map in order to obtain an NSS signature, respectively fingerprint.
- the physicochemical properties of the NSS sample are inferred from the NSS sample map values, i.e. all physicochemical properties of the NSS sample are available, respectively derivable, from map values like a fingerprint.
- NSS and NDDS are understood to refer to systems (or matrices) suspended in a solvent, wherein the term “solvent” refers to a substance, which in this case can dissolve or dilute solids, particularly NSS, with or without modulating their chemical or physical structure.
- solvents utilized are organic or water-based or organic-inorganic (hybrid) solvents or ionic liquids, such as, e.g., water, salt solutions, cell culture media or other biologically relevant solutions such as serum and blood.
- the term “NSS” also includes those "NSS" which are modulated with regard to their chemical or physical structure by the solvent.
- the "sedimentation analysis map” may also include characteristics associated with the NSS and NDDS of interest which have been determined by an independent technology that are used to complement said NDDS physicochemical properties in conjunction with AUC-derived measurements.
- NSS refers to any characteristic that enables the classification of a particular system.
- the parameter is an element of a system that is useful, or critical, when identifying the system, or when evaluating its performance, status, condition, etc..
- NSS are characterized by parameters such as absorbance or refraction, relating to the optical system used for monitoring the behavior of the NSS of interest during sedimentation, in particular AUC; the monitoring of the absorbance across the cell at different values of radii is the most versatile and sensitive method to measure sedimentation behavior of the NSS in question.
- absorbance or refraction relating to the optical system used for monitoring the behavior of the NSS of interest during sedimentation, in particular AUC; the monitoring of the absorbance across the cell at different values of radii is the most versatile and sensitive method to measure sedimentation behavior of the NSS in question.
- refraction detection e.g.
- a difference in refraction between the sample sector (sample in solvent) and the reference sector (solvent only) is measured.
- absorbance detection a difference in absorbance between the sample sector (sample in solvent) and the reference sector (solvent only) is measured; alternatively direct sample sector measurements are possible in intensity mode. Detection is proportional to concentration and it may be used to detect particles at suitable concentrations.
- refraction is able to monitor also objects such as polymers that do not have a suitable light absorbing center/property or emitting center/property. While absorbance and refraction are considered simple parameters in the context of the present invention, NSS also may be characterized by degradation kinetics, which are the most complex but also most insightful parameters.
- Data analysis can be performed employing numerical methods for solution of the LAMM equation (via molecular dynamics or numerical approximation since an analytical solution is difficult), or by means of graphical methods in case computers and/or other means of analysis are unavailable.
- the method according to the present invention advantageously allows the in situ assessment of multifunctional NSS using sedimentation processes, in particular AUC, and particularly under native and relevant biological sample conditions.
- the sample of which a physicochemical property is to be determined, undergoes a limited number of measurements, the results of which are mapped to a multi-dimensional sedimentation analysis map, allowing the physicochemical properties of the sample to be inferred therefrom. It therefore provides a calibration-free, reliable, widely applicable and well-characterized technique for characterizing NSS, serving the entire range of particle sizes and allowing the application of a wide variety of solution conditions without a dilution requirement during analysis.
- the parameter degradation kinetics may comprise physical parameter dependent degradation and/or chemical parameter dependent degradation.
- physical parameter dependent degradation refers to degradation that is caused by varying the energy supplied to the sample, i.e. thermal energy, electric current, ultraviolet radiation, or X-rays.
- temperature dependent degradation in an NSS sample may be measured at 37°C and compared to measurements at 4°C or 20°C and/or different times.
- Chemical parameter dependent degradation in contrast, refers to degradation caused by varying ambient conditions of the sample, i.e. by varying, for example, the concentration of protons (pH) or of an oxidizing or reducing agent.
- biological parameter dependent degradation refers to the presence of e.g. enzymes in the solvent, causing degradation of the NSS in a sample.
- NSS concentration refers to the relative concentrations of the complete NSS and its component species. It is simply readable from the optical density or any detector signal before, during, and after sedimentation, respectively by the area under the differential sedimentation coefficient distribution curve, i.e. inverse intensities over units S. Choice of angular velocities allows for selective fractionation of components in the sample.
- NSS dispersity and NSS aggregates refer to properties relating to the distribution of the NSS in the given solvent, wherein said properties may be derived directly from the respective sedimentation velocity profile. The same applies to the properties of NSS integrity and NSS stability.
- NSS integrity may comprise the integrity of the NSS in a solvent selected from the group comprising water, salt solution, organic solvent, and biologically relevant fluids.
- a solvent is a substance that dissolves or disperses a solute, i.e. an NSS, resulting in a solution / dispersion.
- organic solvents may also suitably used, e.g. for storing NSS.
- biologically relevant fluid refers to a solvent relevant to living systems, such as cell culture or organisms.
- a biologically relevant fluid according to the present invention is cell culture medium, serum, or blood.
- the complex polymeric system may comprise a targeting dye moiety and it is also preferred, when it may comprise a stabilizer, preferably surfactant.
- a complex NSS may be composed of a biodegradable polymer (such as poly (lactic co-glycolid), PLGA) partially functionalized by a targeting dye moiety, it may carry an encapsulated drug and may be stabilized in solution by surfactant partially incorporated into the NSS due to the preparation process.
- the number of measurements to be performed per sample may be two plus at least one measurement / component changed relative to the NSS of interest.
- the number of measurements to be performed per sample may be two, in case of viscosity to be determined, plus possible required measurements whose number depends on the components changed to the known NSS.
- the NSS may comprise a solvent-derived physical and/or chemical modification.
- This modification in form of a "corona” may be used to gauge the suitability for use of the specific NSS in biological fluids.
- the NSS surface may be modified by attachment of Biotin-streptavidin-antibodies ("antibody corona").
- antibody corona Biotin-streptavidin-antibodies
- the binding of components to the particle in form of a corona or covalently through particle design strategies can be studied quantitatively as well.
- the interaction of antibodies with the particle surface and the impact on its integrity in the fluid can also be seen.
- the invention in a second aspect, relates to a system for performing the method described above, wherein the system comprises multi-dimensional sedimentation analysis map generating means for generating a multi-dimensional sedimentation analysis map associated with the NSS of interest; means for selecting sample-dependent sedimentation AUC parameters; means for determining sedimentation coefficient value/parameter in the sample; means for inserting sample sedimentation coefficient values onto the sedimentation analysis map to obtain an NSS sample map value; calculation means for inferring from the NSS sample map value the physicochemical properties for the NSS sample, i.e. for the NSS sample of interest.
- Fig. 1 shows a schematic protocol for characterizing an unknown, complex NSS with respect to different parameters and physicochemical properties.
- This schematic protocol makes reference to the initial step of the method of the invention, i.e. generating the multi-dimensional sedimentation analysis map.
- term "unknown NSS” refers to an NSS comprising a matrix, such as PLGA, in addition to known components at known concentrations, wherein the physicochemical properties of the complete system and the respective components are yet uncharacterized utilizing AUC methods.
- the NSS of interest is a complex structure comprising the following components: matrix (which is not studied individually), a drug, a targeting moiety, a stabilizer (surfactant) and optionally one or more additives.
- the NSS is suspended / dissolved in a solvent.
- Concentration series of the complete NSS and of each component of the NSS are subjected to AUC under different NSS conditions (complex parameter: degradation kinetics, which depends, e.g. on temperature, pH, etc.) using different parameters of measurement, such as optical detection (depicted here: absorption, refractive index) and rotor velocity (rpm).
- density is a complex parameter (like the parameter "degradation kinetics”), which is inversely related to the partial specific volume of an NSS and may be, e.g., derived from AUC sedimentation equilibrium techniques by subjecting the NSS to AUC in a solvent gradient until equilibrium with the solvent is attained.
- the density of a particle may be determined utilizing the sedimentation coefficients of the particle in two solvents of (known) different density and viscosity, such as e.g. mixtures of D 2 O/H 2 O, and calculating the partial specific volume respectively, by its inverse, the density.
- the viscosity of the solvent and of the suspended NSS may be determined from measurements; alternatively, it may be derived from reference tables or the like.
- the complete NSS and its main components have to be subjected to AUC analysis in order to generate a multi-dimensional sedimentation analysis map.
- all "links" which are depicted in Fig.
- FIG. 2 (a)-(c) schematic protocols are depicted exemplifying the steps required for characterization of unknown NSS and partially known NSS samples. In case of a fully unknown NSS, the schematic protocol of Fig. 1 has to be performed.
- Fig. 2 (a) depicts a schematic protocol for characterizing an NSS sample, in particular an NDDS sample, wherein "NDDS" refers to a nanoscale drug delivery system, which is an NSS additionally comprising a drug.
- the depicted NDDS sample is, however, only partly identical to an established NDDS.
- the NDDS comprises the same main constituents as described in the above example (see Fig. 2 (a) ) but differs with respect to the drug and the targeting moiety.
- the links between the new NDDS and the components drug and targeting moiety on the one side and the parameters density, viscosity, and optical detection have to be resolved, resulting in a very significant reduction of the required AUC measurements.
- the sedimentation coefficient values/parameter/concentration series of the complete NDDS and its possible components e.g. drug, targeting moiety
- the physicochemical properties of the NDDS contained in the sample may be determined with high precision and in a timely manner.
- Fig. 2 (b) the same schematic protocol for characterizing an NSS (no drug load) sample based on gold-nanorods is shown.
- the sample containing the gold-nanorods differs from an established gold-nanorod NSS with respect to the suspension medium.
- a patient derived NSS sample may be characterized, requiring the characterization of patient-specific medium (blood or a dilution thereof) in order to derive physicochemical properties from the multi-dimensional sedimentation analysis map, which - for reasons of general applicability - does not comprise patient specific data.
- the method of the present invention allows for a precise and rapid characterization of NSS samples once the underlying NSS system and its components have been established and validated.
- the system also may be used to study conveniently modifications of existing established and validated NSS systems, wherein modifications only relate to components of NSS. In that way, the method of the invention may also be used in the design and testing of new NSS species.
- Sedimentation velocity experiments were performed with a ProteomeLab XL-I analytical ultracentrifuge (Beckman Coulter Instruments, Brea, CA), using double-sector epon centerpieces with a 12 mm optical path length. The cells were placed in an An-50 Ti eight-hole rotor. Typically, sedimentation velocity profile scans were performed right after accelerating the AUC to 3,000 rpm and after 52 minutes. Subsequently, a rotor speed of 10,000 rpm was used for NSS sedimentation velocity experiments. In instances, a rotor speed of 42,000 rpm was used to resolve further details of remaining supernatant (SN), particularly PVA, that was as well investigated via sedimentation velocity experiments at 42,000 rpm.
- SN remaining supernatant
- the sedimentation protocol can simply be adapted to the individual NSS by choosing a speed between 1,000 to 60,000 rpm or more.
- the cells were filled with ca. 440 ⁇ l sample solution in water and with ca. 420 ⁇ l H 2 O or D 2 O/H 2 O as the reference.
- RI reactive index
- Suitable scans were selected for data evaluation with SEDFIT using the Is-g*(s) model, i.e. by least squares boundary modelling with a Tikhonov-Phillips Regularization procedure and by assuming non-diffusing species.
- This model results in an apparent differential distribution of sedimentation coefficients, s.
- Respective integration of the distributions was used for estimating signal (weight) averages of sedimentation coefficients, s, and concentrations, c, via the integral of the differential sedimentation coefficient distributions.
- NSSs in solution are described by the size of hydrodynamic equivalent spheres, i.e. their hydrodynamic diameter, d h,NSS .
- d h,NSS hydrodynamic diameter
- u NSS in first approximation, is inversely proportional to NSS density, , and desired for NSS size estimations.
- the amount of drug in the NDDS 1 substantially decreased with a concomitant increase of free drug in the SN. For example, after two weeks of storage of NDDS 1 at ambient temperature, 20% of drug has entered the particle surrounding liquid concomitant by 20% reduced signal intensity from the particle entity. Also observed was the absence of aggregates for the first two weeks of NDDS 1 storage (see also Fig. 3 (a) ) but at apparently increased particle sizes as seen in the Is-g*(s) distribution shifting to larger values of sedimentation coefficients ( Fig. 5 (a)-(c) ). Allowing for further uncontrolled NDDS 1 degradation at room temperature, resulted in the observation of aggregates after four weeks storage at ambient.
Landscapes
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Dispersion Chemistry (AREA)
- Investigating Or Analysing Materials By Optical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19157202.3A EP3696534A1 (fr) | 2019-02-14 | 2019-02-14 | Procédé pour déterminer les propriétés physicochimiques de systèmes nanométriques (nss) |
US17/310,592 US12061142B2 (en) | 2019-02-14 | 2020-02-05 | Method for determining physicochemical properties of nanoscale systems (NSS) |
PCT/EP2020/052816 WO2020164983A1 (fr) | 2019-02-14 | 2020-02-05 | Procédé de détermination de propriétés physico-chimiques de systèmes nanométriques (nss) |
DE20702332.6T DE20702332T1 (de) | 2019-02-14 | 2020-02-05 | Verfahren zur bestimmung von physikochemischen eigenschaften von nanoskaligen systemen (nss) |
CN202080012510.4A CN113424042B (zh) | 2019-02-14 | 2020-02-05 | 测定纳米级系统(nss)的理化性质的方法 |
JP2021546692A JP7232924B2 (ja) | 2019-02-14 | 2020-02-05 | ナノスケール系(nss)の物理化学的性質を確認するための方法 |
CA3127146A CA3127146C (fr) | 2019-02-14 | 2020-02-05 | Procede de determination de proprietes physico-chimiques de systemes nanometriques (nss) |
EP20702332.6A EP3924717A1 (fr) | 2019-02-14 | 2020-02-05 | Procédé de détermination de propriétés physico-chimiques de systèmes nanométriques (nss) |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP19157202.3A EP3696534A1 (fr) | 2019-02-14 | 2019-02-14 | Procédé pour déterminer les propriétés physicochimiques de systèmes nanométriques (nss) |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3696534A1 true EP3696534A1 (fr) | 2020-08-19 |
Family
ID=65440870
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP19157202.3A Pending EP3696534A1 (fr) | 2019-02-14 | 2019-02-14 | Procédé pour déterminer les propriétés physicochimiques de systèmes nanométriques (nss) |
EP20702332.6A Pending EP3924717A1 (fr) | 2019-02-14 | 2020-02-05 | Procédé de détermination de propriétés physico-chimiques de systèmes nanométriques (nss) |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP20702332.6A Pending EP3924717A1 (fr) | 2019-02-14 | 2020-02-05 | Procédé de détermination de propriétés physico-chimiques de systèmes nanométriques (nss) |
Country Status (7)
Country | Link |
---|---|
US (1) | US12061142B2 (fr) |
EP (2) | EP3696534A1 (fr) |
JP (1) | JP7232924B2 (fr) |
CN (1) | CN113424042B (fr) |
CA (1) | CA3127146C (fr) |
DE (1) | DE20702332T1 (fr) |
WO (1) | WO2020164983A1 (fr) |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE793152A (fr) * | 1971-12-22 | 1973-06-21 | Union Carbide Corp | Procede d'analyse spectrophotometrique |
US5095451A (en) * | 1989-07-13 | 1992-03-10 | E. I. Du Pont De Nemours And Company | Centrifuge particle size analyzer |
DE19729352A1 (de) * | 1997-07-09 | 1999-01-14 | Basf Ag | Zentrifugierverfahren zur Probencharakterisierung |
WO1999046047A2 (fr) * | 1998-03-10 | 1999-09-16 | Large Scale Proteomics Corporation | Detection et caracterisation des micro-organismes |
JP4574962B2 (ja) * | 2003-07-25 | 2010-11-04 | ワイアット テクノロジー コーポレイション | 小粒子の溶液を特徴付けるための方法および装置 |
FR2872910B1 (fr) * | 2004-07-07 | 2006-10-13 | Nanoraptor Sa | Composant optique pour l'observation d'un echantillon nanometrique, systeme comprenant un tel composant, procede d'analyse mettant en oeuvre ce composant, et leurs applications |
KR102131575B1 (ko) * | 2009-07-08 | 2020-07-08 | 클레네 나노메디슨, 인크. | 의학적 치료를 위한 신규한 금계 나노결정 및 이를 위한 전기화학 제조 방법 |
GB0917242D0 (en) * | 2009-10-01 | 2009-11-18 | Medical Res Council | Acetyl lysine incorporation with tRNA synthetase |
GB201103064D0 (en) * | 2011-02-23 | 2011-04-06 | Isis Innovation | Particle detection |
TWI425914B (zh) * | 2011-03-21 | 2014-02-11 | Food Industry Res & Dev Inst | 含高濃度奈米/次微米疏水性機能化合物之水相分散液之製備方法 |
DE102012100065A1 (de) * | 2012-01-05 | 2013-07-11 | Frederic Laager S.U.P.E.R. Lab | Verfahren zur Analyse von Proben und Systeme hierfür |
WO2015036868A2 (fr) * | 2013-09-12 | 2015-03-19 | King Abdullah University Of Science And Technology | Fractionnement à l'échelle du gramme de nanodiamants par ultracentrifugation sur gradient de densité |
US20160266141A1 (en) * | 2013-10-03 | 2016-09-15 | Bioanalytix, Inc. | Mass spectrometry-based method for identifying and maintaining quality control factors during the development and manufacture of a biologic |
EP3247793A1 (fr) * | 2015-01-20 | 2017-11-29 | Genzyme Corporation | Ultracentrifugation analytique pour la caractérisation de particules virales recombinées |
EP3271057B1 (fr) * | 2015-03-19 | 2019-09-04 | The University of Connecticut | Systèmes et procédés pour la fabrication continue de formulations de médicament liposomales |
-
2019
- 2019-02-14 EP EP19157202.3A patent/EP3696534A1/fr active Pending
-
2020
- 2020-02-05 JP JP2021546692A patent/JP7232924B2/ja active Active
- 2020-02-05 CN CN202080012510.4A patent/CN113424042B/zh active Active
- 2020-02-05 WO PCT/EP2020/052816 patent/WO2020164983A1/fr unknown
- 2020-02-05 DE DE20702332.6T patent/DE20702332T1/de active Pending
- 2020-02-05 CA CA3127146A patent/CA3127146C/fr active Active
- 2020-02-05 US US17/310,592 patent/US12061142B2/en active Active
- 2020-02-05 EP EP20702332.6A patent/EP3924717A1/fr active Pending
Non-Patent Citations (3)
Title |
---|
ANDREAS WINTER ET AL: "Synthesis and characterization of metallo-supramolecular polymers", CHEMICAL SOCIETY REVIEWS, vol. 45, no. 19, 1 January 2016 (2016-01-01), UK, pages 5311 - 5357, XP055611204, ISSN: 0306-0012, DOI: 10.1039/C6CS00182C * |
MIRCEA RASA ET AL: "Progress in the characterization of synthetic (supramolecular) polymers by analytical ultracentrifugation", SOFT MATTER, vol. 2, no. 7, 1 January 2006 (2006-01-01), pages 561 - 572, XP055611227, ISSN: 1744-683X, DOI: 10.1039/B601666A * |
W. MACHTLE; L. BORGER: "Analytical Ultracentrifugation of Polymers and Nanoparticles", 2006, SPRINGER |
Also Published As
Publication number | Publication date |
---|---|
US20220099547A1 (en) | 2022-03-31 |
JP2022520194A (ja) | 2022-03-29 |
CN113424042A (zh) | 2021-09-21 |
CN113424042B (zh) | 2024-08-16 |
CA3127146C (fr) | 2023-09-19 |
JP7232924B2 (ja) | 2023-03-03 |
DE20702332T1 (de) | 2023-04-27 |
US12061142B2 (en) | 2024-08-13 |
CA3127146A1 (fr) | 2020-08-20 |
EP3924717A1 (fr) | 2021-12-22 |
WO2020164983A1 (fr) | 2020-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Modena et al. | Nanoparticle characterization: what to measure? | |
Bhattacharjee | DLS and zeta potential–what they are and what they are not? | |
Banerji et al. | Examination of nonendocytotic bulk transport of nanoparticles across phospholipid membranes | |
Gu et al. | Polymeric materials in drug delivery | |
Kestens et al. | Improved metrological traceability of particle size values measured with line-start incremental centrifugal liquid sedimentation | |
Cinar et al. | In situ, quantitative assessment of multifunctional nanoscale drug delivery systems in human serum | |
Coglitore et al. | Unexpected hard protein behavior of BSA on gold nanoparticle caused by resveratrol | |
Kishore et al. | The effect of particle-scale dynamics on the macroscopic properties of disk-shaped colloid–polymer systems | |
Lauten et al. | Adsorption and desorption of unmodified and hydrophobically modified ethyl (hydroxyethyl) cellulose on polystyrene latex particles in the presence of ionic surfactants using dynamic light scattering | |
Foreman-Ortiz et al. | Nanoparticle tracking analysis and statistical mixture distribution analysis to quantify nanoparticle–vesicle binding | |
US12061142B2 (en) | Method for determining physicochemical properties of nanoscale systems (NSS) | |
Lulevich et al. | Investigation of molecular weight and aging effects on the stiffness of polyelectrolyte multilayer microcapsules | |
Kharchenko et al. | Effect of poly (sodium 4-styrenesulfonate) on the ionization constants of acid-base indicator dyes in aqueous solutions | |
Huang et al. | Phase behavior and rheology of attractive rod-like particles | |
Heider et al. | Structural characterization of individual vesicles using fluorescence microscopy | |
Lauten et al. | Colloid polymer interactions and aggregation in aqueous mixtures of polystyrene latex, sodium dodecyl sulfate, and a hydrophobically modified polymer: A dynamic light scattering study | |
Singh et al. | Constrained dynamics of DNA oligonucleotides in phase-separated droplets | |
Li et al. | Gentle immobilization of nonionic polymersomes on solid substrates | |
Deckel et al. | Using holographic microscopy to measure the effect of confinement on crowding agents in lipid vesicles | |
Matsukuma et al. | UCST‐type phase transition driven by protein‐derived polypeptide employing gelatin and chitosan | |
Das et al. | A Global Scenario on the Dynamics of Excited State Proton Transfer of Pyranine in the Mixed Micellar Assemblies: Role of Water Accessibility in the Probe Location+ | |
Cheng et al. | Transport of nanoparticulate material in self-assembled block copolymer micelle solutions and crystals | |
Kohli et al. | Contrasting nanoparticle diffusion in branched polymer and particulate solutions: more than just volume fraction | |
Wang | Development of the Top Layer Method for Measuring the Diffusion Kinetics of Small Molecules in Hydrogels | |
Lee | Nanoparticle mobility in viscoelastic media |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION HAS BEEN PUBLISHED |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20210217 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 40035361 Country of ref document: HK |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20220421 |